Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Covered self-expandable metallic stents (CMSs) are widely used for malignant distal biliary obstructions (MDBOs)caused by pancreatic carcinoma. This study compared the efficacy and safety of the laser-cut-type and braided-type CMSs. Methods: To palliate MDBOs caused by pancreatic carcinoma, the laser-cut-type CMSs was used from April 2014 to March 2017, andthe braided-type CMSs was used from April 2017 to March 2019. The tested self-expandable metallic stents were equipped with differentanti-migration systems. Results: In total, 47 patients received CMSs for MDBOs (24 laser-cut type, 23 braided-type). The time to recurrent biliary obstruction(TRBO) was significantly longer in the braided-type CMSs (p=0.0008), and the median time to stent dysfunction or patient death was141 and 265 days in the laser-cut-type CMSs and braided-type CMSs, respectively (p=0.0023). Stent migration was the major cause ofstent dysfunction in both groups, which occurred in 37.5% of the laser-cut-type CMSs and 13.0% of the braided-type CMSs. Therewere no differences in the survival duration between the groups. Conclusions: The TRBO was significantly longer for the braided-type CMSs with an anti-migration system than for the laser-cut-type. Stent migration tended to be less frequent with the braided-type CMSs than with the laser-cut-type CMSs.
Abstract
Background/Aims: Covered self-expandable metallic stents (CMSs) are widely used for malignant distal biliary obstructions (MDBOs)caused by pancreatic carcinoma. This study compared the efficacy and safety of the laser-cut-type and braided-type CMSs. Methods: To palliate MDBOs caused by pancreatic carcinoma, the laser-cut-type CMSs was used from April 2014 to March 2017, andthe braided-type CMSs was used from April 2017 to March 2019. The tested self-expandable metallic stents were equipped with differentanti-migration systems. Results: In total, 47 patients received CMSs for MDBOs (24 laser-cut type, 23 braided-type). The time to recurrent biliary obstruction(TRBO) was significantly longer in the braided-type CMSs (p=0.0008), and the median time to stent dysfunction or patient death was141 and 265 days in the laser-cut-type CMSs and braided-type CMSs, respectively (p=0.0023). Stent migration was the major cause ofstent dysfunction in both groups, which occurred in 37.5% of the laser-cut-type CMSs and 13.0% of the braided-type CMSs. Therewere no differences in the survival duration between the groups. Conclusions: The TRBO was significantly longer for the braided-type CMSs with an anti-migration system than for the laser-cut-type. Stent migration tended to be less frequent with the braided-type CMSs than with the laser-cut-type CMSs.
참고문헌 (43)
- Soehendra N, "Palliative bile duct drainage : a new endoscopic method of introducing a transpapillary drain", Endoscopy, 12, pp.8~11 (1980)
- Huibregtse K, "Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis", Gut, 23, pp.371~375 (1982)
- Walta DC, "Endoscopic biliary stents and obstructive jaundice", Am J Surg, 153, pp.444~447 (1987)
- Speer AG, "Endoscopic management of malignant biliary obstruction : stents of 10 French gauge are preferable to stents of 8 French gauge", Gastrointest Endosc, 34, pp.412~417 (1988)
- Huibregtse K, "Endoscopic placement of expandable metal stents for biliary strictures : a preliminary report on experience with 33 patients", Endoscopy, 21, pp.280~282 (1989)
- Davids PH, "Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction", Lancet, 340, pp.1488~1492 (1992)
- Knyrim K, "A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct", Endoscopy, 25, pp.207~212 (1993)
- Lammer J, "Common bile duct obstruction due to malignancy : treatment with plastic versus metal stents", Radiology, 201, pp.167~172 (1996)
- Prat F, "A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct", Gastrointest Endosc, 47, pp.1~7 (1998)
- Isayama H, "Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer(JM-test) : covered wallstent versus doublelayer stent", Dig Endosc, 23, pp.310~315 (2011)
- Isayama H, "A prospective randomised study of"covered"versus"uncovered"diamond stents for the management of distal malignant biliary obstruction", Gut, 53, pp.729~734 (2004)
- Kitano M, "Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma : a randomized multicenter trial", Am J Gastroenterol, 108, pp.1713~1722 (2013)
- Misra SP, "Reflux of duodenal contents and cholangitis in patients undergoing self-expanding metal stent placement", Gastrointest Endosc, 70, pp.317~321 (2009)
- Okamoto T, "Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis", Gastrointest Endosc, 63, pp.792~796 (2006)
- Kin T, "Feasibility of biliary stenting to distal malignant biliary obstruction using a novel designed metal stent with duckbill-shaped anti-reflux valve", Dig Endosc, 33, pp.648~655 (2021)
- Kogure H, "A prospective multicenter study of a fully covered metal stent in patients with distal malignant biliary obstruction : WATCH-2 study", Dig Dis Sci, 63, pp.2466~2473 (2018)
- Park DH, "Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction : a cohort comparative analysis", Clin Gastroenterol Hepatol, 4, pp.790~796 (2006)
- Isayama H, "Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction : the WATCH study", Gastrointest Endosc, 76, pp.84~92 (2012)
- 김재윤, "Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction", Gut and Liver, 11(3), pp.440~446 (2017), 거트앤리버 소화기연관학회협의회
- Conio M, "Covered versus uncovered self-expandable metal stent for palliation of primary malignant extrahepatic biliary strictures : a randomized multicenter study", Gastrointest Endosc, 88, pp.283~291 (2018)
- Kullman E, "Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction : results from a randomized, multicenter study", Gastrointest Endosc, 72, pp.915~923 (2010)
- Telford JJ, "A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction", Gastrointest Endosc, 72, pp.907~914 (2010)
- Yang MJ, "Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction : a randomized controlled trial", Scand J Gastroenterol, 50, pp.1490~1499 (2015)
- Ung KA, "Covered and uncovered self-expandable metallic Hanarostents are equally efficacious in the drainage of extrahepatic malignant strictures : results of a double-blind randomized study", Scand J Gastroenterol, 48, pp.459~465 (2013)
- Costamagna G, "A new partially covered nitinol stent for palliative treatment of malignant bile duct obstruction : a multicenter single-arm prospective study", Endoscopy, 43, pp.317~324 (2011)
- Gomez-Oliva C, "Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction : results of a large prospective series", Surg Endosc, 26, pp.222~229 (2012)
- Soderlund C, "Nitinol versus steel partially covered self-expandable metal stent for malignant distal biliary obstruction : a randomized trial", Endoscopy, 46, pp.941~948 (2014)
- Yokota Y, "Partially covered metal stents have longer patency than uncovered and fully covered metal stents in the management of distal malignant biliary obstruction : a retrospective study", BMC Gastroenterol, 17, pp.105~ (2017)
- Isayama H, "Measurement of radial and axial forces of biliary self-expandable metallic stents", Gastrointest Endosc, 70, pp.37~44 (2009)
- Isayama H, "TOKYO criteria 2014 for transpapillary biliary stenting", Dig Endosc, 27, pp.259~264 (2015)
- ASGE Standards of Practice Committee, "Adverse events associated with ERCP", Gastrointest Endosc, 85, pp.32~47 (2017)
- Eisenhauer EA, "New response evaluation criteria in solid tumours : revised RECIST guideline(version 1. 1)", Eur J Cancer, 45, pp.228~247 (2009)
- Kanda Y, "Investigation of the freely available easy-to-use software"EZR"for medical statistics", Bone Marrow Transplant, 48, pp.452~458 (2013)
- Yokoe M, "Tokyo guidelines 2018 : diagnostic criteria and severity grading of acute cholecystitis(with videos)", J Hepatobiliary Pancreat Sci, 25, pp.41~54 (2018)
- Hiroyuki Isayama, "A Novel, Fully Covered Laser-Cut Nitinol Stent with Antimigration Properties for Nonresectable Distal Malignant Biliary Obstruction: A Multicenter Feasibility Study", Gut and Liver, 7(6), pp.725~730 (2013), 거트앤리버 소화기연관학회협의회
- Saito Kei, "A Prospective Multicenter Study of Partially Covered Metal Stents in Patients Receiving Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: BTS-NAC Study", Gut and Liver, 15(1), pp.135~141 (2021), 거트앤리버 소화기연관학회협의회[DOI]
- Marui S, "Utility of laser-cut covered self-expandable metal stents for unresectable malignant distal biliary obstruction : a single-center experience", Endoscopy, 52, pp.664~668 (2020)
- Park DH, "Anchoring flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with benign biliary strictures : a multicenter, prospective, comparative pilot study(with videos)", Gastrointest Endosc, 73, pp.64~70 (2011)
- Minaga K, "Evaluation of anti-migration properties of biliary covered self-expandable metal stents", World J Gastroenterol, 22, pp.6917~6924 (2016)
- Nakai Y, "Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction", J Gastroenterol, 48, pp.1293~1299 (2013)
- Nakai Y, "Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer", J Gastroenterol Hepatol, 29, pp.1744~1749 (2014)
- Conroy T, "FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer", N Engl J Med, 364, pp.1817~1825 (2011)
- Von HoffDD, "Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine", N Engl J Med, 369, pp.1691~1703 (2013)
